Naxos disease is a rare genetic heart condition that also affects the skin and hair. It causes thick, rough skin on the palms and soles, woolly or tightly curled hair, and heart rhythm problems. Signs often appear in infancy or childhood, and heart issues usually progress during the teenage years or early adulthood. The condition is lifelong, and the risk of dangerous heart rhythms can raise the chance of sudden death without treatment. Care includes heart rhythm monitoring, medicines, ablation or an implantable defibrillator, and skin care to manage discomfort and cracking.
Overview
Naxos diseaseSymptoms
Naxos disease features woolly, tightly curled hair from birth and thickened skin on the palms and soles developing in childhood. Heart rhythm problems emerge later—palpitations, dizziness, fainting with exercise—and may rarely cause cardiac arrest. Early signs of Naxos disease vary.
Outlook and prognosis
Many living with Naxos disease can lead active lives with regular heart monitoring, medicines to control rhythm, and timely procedures when needed. Risks often rise in the teens or young adulthood, so early symptoms of Naxos disease deserve prompt care. Family screening supports safer, longer-term outcomes.
Causes and risk factors
Naxos disease is caused by autosomal recessive variants in desmosomal genes, usually JUP or DSP. Risk is higher when both parents are carriers, in consanguineous families, or founder populations. Intense endurance exercise may exacerbate disease expression and arrhythmia risk.
Genetic influences
Genetics are central in Naxos disease. It’s usually inherited in an autosomal recessive pattern, with changes in desmosomal genes (commonly JUP or DSP) driving the heart and skin features. Family history, carrier status, and genetic testing strongly influence risk and management.
Diagnosis
Doctors suspect Naxos disease from its clinical features: woolly hair, thickened palms/soles, plus heart rhythm problems. Confirmation uses cardiac tests (ECG, echocardiogram, cardiac MRI, Holter) and genetic testing; genetic diagnosis of Naxos disease also supports family screening.
Treatment and drugs
Treatment for Naxos disease focuses on protecting the heart and skin. Care often includes rhythm medicines, catheter ablation, or an implantable cardioverter-defibrillator to prevent dangerous heart rhythms, plus careful exercise guidance. Skin features are managed with moisturizers, keratolytics, and specialist dermatology care.
Symptoms
People with Naxos disease often notice changes in hair, the skin of the palms and soles, and heart rhythm that can affect daily routines. Parents may see woolly hair in infancy and, later, thick skin on the hands and feet; these early features of Naxos disease are often followed by heart issues in the teen years or young adulthood. Day to day, it can feel like managing tender, cracked skin on the hands or sore feet while also dealing with occasional fluttering or racing heartbeats. Not everyone has the same pattern or timing, and heart-related signs can range from mild palpitations to fainting.
Tightly curled, coarse hair is present from birth. It does not harm health but is a telltale sign of Naxos disease. Hair care may take extra time.
The skin on the hands and feet becomes thick, tough, and may crack. This can make walking, sports, writing, or manual work uncomfortable. Cracks can be sore and may need gentle care.
A fluttering, pounding, or skipping heartbeat may come in bursts. These often relate to abnormal heart rhythms (arrhythmias) in Naxos disease. They may be more noticeable with exercise or strong emotions.
Sudden lightheadedness, near-fainting, or brief blackouts can occur. Episodes may follow exertion or happen at rest. They can be a sign of a fast, unstable heart rhythm.
How people usually first notice Naxos disease?
Many first notice Naxos disease when a child’s palms and soles become unusually thick and rough in early childhood, sometimes cracking or turning yellowish, and their hair looks woolly or tightly curled from birth. As the child grows, faint heart-related signs may appear—like tiring faster than peers, fainting during exercise, or irregular heartbeats—prompting a doctor to check the heart. This pattern of woolly hair plus thickened palms/soles often leads clinicians to suspect arrhythmogenic right ventricular cardiomyopathy of the Naxos type, which is how the first signs of Naxos disease are typically recognized.
Types of Naxos disease
Naxos disease is a genetic heart–skin condition with recognizable variants linked to different genes in the heart’s cell-connection proteins. These variants share a core pattern—risk of abnormal heart rhythms and a thick, woolly texture of hair and skin on the palms and soles—but severity and timing can differ. Symptoms don’t always look the same for everyone. Below are the main, widely accepted variants people may see discussed when reading about types of Naxos disease.
JUP (plakoglobin)
This classic variant is tied to changes in the JUP gene and often starts in the teen years. People may have woolly hair from birth, thickened palms/soles in childhood, and right-sided heart rhythm problems in adolescence.
DSP (desmoplakin)
Sometimes called a Carvajal-like form when left-sided heart involvement is prominent. Skin and hair features are similar, but heart changes can show up earlier or more on the left ventricle, raising arrhythmia risk.
DSG2 (desmoglein-2)
This less common variant links to DSG2 and may present later. People can have milder skin signs yet still develop ventricular arrhythmias or cardiomyopathy over time.
PKP2 (plakophilin-2)
PKP2 variants are well known in arrhythmogenic cardiomyopathy and are occasionally reported with Naxos-like features. Skin findings may be subtle, but rhythm issues and exercise-triggered episodes can occur.
Recessive vs. dominant
Some variants are inherited in a recessive pattern with earlier, more typical hair/skin signs, while others can be dominant with later or fewer skin changes. This difference can affect age at diagnosis and how symptoms cluster across the family.
What genetics can tell you about symptoms
In Naxos disease, inherited changes in desmosome genes (often JUP) weaken the “glue” between heart and skin cells, leading to thick, woolly hair, rough palm–sole skin, and heart rhythm problems that can cause fainting or sudden collapse. Specific variants tend to predict earlier, more severe arrhythmias and scarring of the right ventricle.
Causes and risk factors
Most people with Naxos disease have changes in both copies of a gene called JUP (plakoglobin). Some risks are written in our DNA, passed down through families. Heart problems often surface in the teen years or early adulthood as growth and hormones increase strain on the heart. High-intensity or endurance exercise can speed disease progression and trigger abnormal heart rhythms. Stimulants or severe dehydration can provoke rhythm issues, and family screening can spot early symptoms of Naxos disease.
Environmental and biological risk factors
People often want to know what in their surroundings or bodies might raise the chance of Naxos disease. Doctors often group risks into internal (biological) and external (environmental). For this condition, research so far has not identified specific environmental triggers or other body-based factors that reliably increase its likelihood. Below is what studies have examined regarding environmental and biological risk factors for Naxos disease.
No specific environmental exposure has been shown to increase the chance of Naxos disease. Studies to date have not identified a repeatable trigger across different settings.
Common pregnancy conditions have not been linked to a higher risk of this condition. Routine prenatal care supports overall fetal health.
Current evidence does not show that infections during pregnancy raise the risk. Preventing and treating infections remains important for general pregnancy health.
Research has not found a consistent link between advanced parental age and Naxos disease. Available reports do not show a clear age-related pattern.
Genetic risk factors
Genetic causes of Naxos disease center on changes in desmosomal genes that help heart and skin cells stick together, most often the JUP gene. The condition usually follows an autosomal recessive pattern, meaning two altered copies are needed. Family origin and related parents can increase the chance that both partners carry the same rare change. Science continues to uncover how these elements interact.
JUP gene variants: Most people with this condition have harmful changes in the JUP gene (plakoglobin), a key part of the links that hold cells together. These changes weaken heart muscle connections and contribute to irregular rhythms and scarring.
Autosomal recessive inheritance: Naxos disease appears when someone inherits two non-working copies of the same gene—one from each parent. When both parents are carriers, each child has a 25% (1 in 4) chance of being affected.
DSP gene overlap: Changes in the related DSP gene can cause a Naxos-like condition with similar hair, skin, and heart features. This genetic overlap can make diagnosis tricky, but the classic form is tied to JUP.
Founder variants: In some families or regions, a single older JUP change became common over generations (founder effect). This raises the local carrier rate and the chance two carriers have a child with Naxos disease.
Related parents: When parents are related by blood, they are more likely to share the same rare JUP change. This increases the odds their children inherit both copies and develop Naxos disease.
Carrier state: Carriers usually have no symptoms and do not develop Naxos disease. Most live normally, though a few may have subtle heart test changes that don’t affect daily life.
Variable expression: Even with the same JUP change, severity and the age when heart issues start can differ between people. Some develop problems in the teens or early adulthood, while others are later.
Lifestyle risk factors
Naxos disease is genetic, and lifestyle habits do not cause it. However, daily choices can influence arrhythmia risk, heart function, and the severity of palm–sole skin symptoms. Understanding how lifestyle affects Naxos disease helps you minimize triggers and protect the heart. Below are practical lifestyle risk factors for Naxos disease to consider with your care team.
High-intensity or competitive sports can accelerate right-ventricular remodeling and trigger dangerous arrhythmias. Limiting to low-to-moderate dynamic activity under medical guidance may reduce events.
Energy drinks, high caffeine, nicotine, and illicit stimulants raise adrenaline and can precipitate ventricular arrhythmias in ARVC/Naxos. Avoiding or minimizing stimulants lowers ectopy and shock risk in those with ICDs.
Heavy or binge drinking destabilizes heart rhythm and can worsen cardiomyopathy. Choosing no alcohol or strict moderation reduces arrhythmia and heart-failure exacerbations.
Dehydration, crash dieting, vomiting, or excessive sauna use can lower potassium or magnesium, provoking ventricular arrhythmias. Consistent hydration and electrolyte-aware nutrition help maintain electrical stability.
Risk prevention
You can’t prevent Naxos disease itself because it’s inherited, but you can lower the chance of dangerous heart rhythm problems and catch issues early. Screenings and check-ups are part of prevention too. Many aim to limit heart strain, avoid common rhythm triggers, and plan ahead for emergencies. Family members may also benefit from genetic counseling and heart screening.
Close relatives can consider genetic counseling and heart tests to find Naxos disease early. Detecting risk early allows monitoring and treatment before symptoms start.
High‑intensity and endurance sports can stress a vulnerable heart in Naxos disease. Many do better with light to moderate activity chosen with a cardiologist.
Scheduled ECGs, Holter monitors, and imaging can track changes in Naxos disease over time. This helps tailor care and spot rhythm risks before they cause symptoms.
For some with Naxos disease, beta‑blockers or other medicines lower rhythm strain. An implanted defibrillator may be considered if the risk of dangerous rhythms is high.
Transmission
Naxos disease is inherited, not contagious—you can’t catch it from someone or spread it through everyday contact. It follows an autosomal recessive pattern: when both parents carry one non-working copy of the same gene, each pregnancy has a 25% (1 in 4) chance of a child with Naxos disease, a 50% (1 in 2) chance of a healthy carrier, and a 25% chance of neither copy. If someone with Naxos disease has children, all will be carriers if their partner is not a carrier; if the partner is a carrier, each child has a 50% chance to have the condition. If you’re wondering how Naxos disease is inherited and what that means for your family, a genetics professional can offer testing and counseling.
When to test your genes
Consider genetic testing if you have a family history of Naxos disease, unexplained fainting or palpitations, or a relative with arrhythmogenic right ventricular cardiomyopathy, especially at a young age. Testing is also reasonable before intense athletics or pregnancy planning. Results can guide heart screening, activity limits, and preventive treatments for you and relatives.
Diagnosis
Naxos disease is usually identified by a mix of recognizable skin and hair features along with heart rhythm changes, then confirmed with specific tests. You might notice thickened skin on the palms and soles or tightly curled, “woolly” hair in childhood, while heart symptoms often appear later. The genetic diagnosis of Naxos disease typically confirms what doctors see on exam and heart testing. Getting a diagnosis is often a turning point toward answers and support.
Doctors look for woolly hair and thickened skin on the palms and soles that start early in life. These clues raise suspicion for Naxos disease when paired with heart rhythm symptoms.
A detailed family and health history can help connect skin, hair, and heart findings across relatives. Patterns such as early rhythm problems or sudden cardiac death in the family support the diagnosis.
An electrocardiogram (ECG) checks the heart’s electrical pattern, and a wearable Holter monitor records rhythms over 24–48 hours. These tests can detect extra beats, abnormal patterns, or pauses that fit Naxos disease.
An ultrasound of the heart looks for changes in size, pumping strength, and wall motion, especially in the right ventricle. These findings can suggest arrhythmogenic changes linked to Naxos disease.
Stages of Naxos disease
Naxos disease often progresses through a few recognizable stages in the heart, though the pace varies from person to person. Early and accurate diagnosis helps you plan ahead with confidence. Early symptoms of Naxos disease may be absent in the heart, while hair and skin changes tend to appear in childhood. Doctors monitor the heart over time to see if and when it moves from rhythm problems to pumping problems.
Concealed early phase
You may feel well with normal activity. The heart’s tests may show small changes, and Naxos disease may be suspected because of long-standing hair or skin signs. Strenuous exercise may carry higher rhythm risk.
Electrical rhythm problems
Palpitations, lightheaded spells, or fainting can start as the heart becomes irritable. Tests may show extra beats or bursts of fast rhythm coming from the right side of the heart.
Right heart changes
The right pumping chamber can stretch and weaken, causing breathlessness with exertion and reduced stamina. Heart scans may show thinning or scarring in that area.
Advanced biventricular stage
Both sides of the heart can be involved, leading to leg swelling, fatigue, and shortness of breath even at rest. The risk of serious rhythm events and heart failure rises, and more intensive treatments are often considered.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with Naxos disease, day-to-day life is shaped more by heart rhythm symptoms than by constant limitations. Early symptoms of Naxos disease can include fainting during exercise, a racing heartbeat that starts and stops suddenly, or feeling unusually wiped out after activity. Skin and hair changes may appear in childhood, but the heart issues often emerge in the teen years or young adulthood. With the right support, the future can be safer and more active than you might expect.
Doctors call this the prognosis—a medical word for likely outcomes. Naxos disease raises the risk of dangerous heart rhythms, especially during strenuous activity, and this risk can lead to sudden cardiac arrest if not addressed. Mortality has fallen in recent decades because of earlier diagnosis, medications to control rhythm, lifestyle adjustments like avoiding high-intensity bursts, and devices such as implantable defibrillators when needed. Some people have few rhythm events for years, while others need closer monitoring and procedures to prevent episodes.
Understanding the prognosis can guide planning and everyday choices. Regular cardiology follow-up, tailored exercise guidance, and prompt treatment of palpitations or fainting can lower risk and improve quality of life. Genetic testing can sometimes provide more insight into prognosis, especially for relatives who may carry the same gene change. Talk with your doctor about what your personal outlook might look like, including whether a defibrillator, medicines, or sports restrictions fit your situation.
Long-term effects
Naxos disease tends to unfold over years, with heart rhythm problems often appearing from adolescence into adulthood and sometimes progressing. Long-term effects vary widely, and ongoing support can help people navigate changes over time. For some, early symptoms of Naxos disease include palpitations or fainting during exercise, while others notice issues later. The skin and hair features usually remain lifelong, while the heart changes can advance and need close follow-up.
Fast, irregular heartbeats can cause pounding in the chest, lightheadedness, or fainting. These episodes may become more frequent or harder to predict over time.
There is an ongoing risk of dangerous rhythms that can lead to collapse. This risk may rise with vigorous exertion in some people with Naxos disease.
The right side of the heart can weaken first, then sometimes both sides, leading to breathlessness, swelling, and fatigue. Daily stamina may slowly decline as the heart’s pumping ability falls.
Activity can bring on palpitations, chest discomfort, or unusual tiredness. Many people with Naxos disease find they need more recovery time after exertion.
How is it to live with Naxos disease?
Living with Naxos disease often means planning around the heart first and everything else second. Many people pace their days to avoid palpitations, dizziness, or fainting, keep up with regular cardiology visits and monitoring devices, and take medicines that can cause fatigue; some need an implanted defibrillator and learn to trust it while also respecting activity limits. Family and friends usually become part of the safety net—recognizing warning signs, knowing how to respond in an emergency, and sharing decisions about sports, travel, and pregnancy—while also supporting the visible skin and hair features that can affect confidence. With a clear care plan, honest communication, and attention to emotional health, many build steady routines that protect the heart without letting the condition define every moment.
Treatment and drugs
Treatment for Naxos disease focuses on protecting the heart, easing symptoms, and preventing sudden complications. Doctors often use heart rhythm medicines (antiarrhythmics), beta‑blockers, and sometimes ACE inhibitors or ARBs to support heart function; an implantable cardioverter‑defibrillator (ICD) may be recommended to prevent life‑threatening rhythm problems. If medicines don’t control dangerous rhythms or heart failure worsens, catheter ablation, a wearable defibrillator while decisions are made, or advanced options like a ventricular assist device or heart transplant may be considered. Alongside medical treatment, lifestyle choices play a role, including avoiding high‑intensity endurance sports that can strain the heart, treating low potassium or magnesium when needed, and following personalized exercise and activity guidance. Keep track of how you feel, and share this with your care team, since plans for Naxos disease are adjusted over time based on symptoms, rhythm monitoring, and imaging results.
Non-drug treatment
Living with Naxos disease often means balancing heart safety with day‑to‑day comfort for skin and activity. Alongside medicines, non-drug therapies can help lower arrhythmia risk, protect the skin, and support well-being. These steps work best when they’re tailored to your personal risk and life stage. Your care team can help you choose options that fit your routines and goals.
In Naxos disease, avoid high-intensity and endurance exercise that can trigger dangerous rhythms. Choose light-to-moderate activities cleared by your cardiologist. This protects the right side of the heart.
Scheduled ECGs, echocardiograms, and rhythm checks track changes over time. Finding early symptoms of Naxos disease complications allows quicker action. Home or wearable monitors may be used between visits.
An implantable cardioverter-defibrillator can stop life-threatening rhythms in people at higher risk with Naxos disease. Doctors weigh your test results, fainting history, and family pattern. It adds protection but does not replace activity limits and follow-up.
Targeted energy can quiet areas that trigger fast heart rhythms. It may reduce shocks if you already have an ICD. It is not a cure, and arrhythmias can return.
Your genes may have an impact on how drugs work for you
Medicines for Naxos disease—especially antiarrhythmics and beta‑blockers—can work differently depending on gene variants that affect heart‑cell proteins and drug‑processing enzymes. Genetic testing may guide drug choice and dose, lowering side‑effects and improving rhythm control.
Pharmacological treatments
Medicines for Naxos disease focus on controlling heart rhythm problems, protecting the heart muscle, and easing thickened skin on the palms and soles. Not everyone responds to the same medication in the same way. Doctors often combine drugs and adjust doses over time to balance benefits and side effects. Here are common medications for Naxos disease used in day-to-day care.
Metoprolol, bisoprolol, or nadolol help steady the heartbeat and reduce dangerous rhythm surges. First-line medications are those doctors usually try first, based on safety and long-term experience in similar heart conditions. Heart rate and blood pressure are checked to guide dosing.
Sotalol, amiodarone, or flecainide may be added if rhythm episodes continue. These can lower the risk of ventricular tachycardia but need monitoring for side effects like low heart rate or prolonged QT. Amiodarone also requires thyroid, liver, and eye checks.
Enalapril or lisinopril (ACE inhibitors), or losartan or valsartan (ARBs), support heart function if weakness or dilation develops. They can ease symptoms and may slow remodeling of the right ventricle. Kidney function and potassium are monitored.
Spironolactone or eplerenone help counter fluid retention and protect the heart over time. They can raise potassium levels, so periodic blood tests are important. Breast tenderness can occur with spironolactone in some people.
Genetic influences
Naxos disease is usually inherited in a recessive way: a child needs two copies of a specific gene change, one from each parent, to develop the condition. These changes affect proteins that help heart muscle and skin cells hold together, which is why rhythm problems can appear alongside features like woolly hair and thickened skin on the palms and soles. A “carrier” means you hold the gene change but may not show symptoms. When both parents are carriers, each pregnancy has a 1 in 4 (25%) chance of a child with Naxos disease, a 1 in 2 (50%) chance of a carrier, and a 1 in 4 (25%) chance of an unaffected child. Genetic testing can confirm the gene involved and help clarify risks for relatives. Severity and the age when heart issues begin can vary even within a family; early symptoms of Naxos disease, such as fainting or a racing heartbeat during exercise, often show up in the teen years.
Is Naxos disease genetic?
Genetics are central in Naxos disease. It’s usually inherited in an autosomal recessive pattern, with changes in desmosomal genes (commonly JUP or DSP) driving the heart and skin features. Family history, carrier status, and genetic testing strongly influence risk and management.
Pharmacogenetics—how genetics influence drug effects
The specific gene change behind Naxos disease can shape arrhythmia risk and how the heart muscle behaves, so it often guides treatment decisions—from when to consider an implantable defibrillator to which medications for Naxos disease are most appropriate. For medicines, differences in drug‑processing genes can change how you respond to beta‑blockers (such as metoprolol), and sometimes to other anti‑arrhythmics and heart‑failure drugs. A “slow metabolizer” may process medicine more slowly, leading to stronger effects or side effects at standard doses, while a “fast metabolizer” may clear it too quickly to help. If anticoagulation is needed for rhythm problems, genetics can affect dosing with warfarin, whereas newer blood thinners are less influenced by known gene differences. Doctors may use genetic and pharmacogenetic testing results alongside your ECG, imaging, and family history to personalize drug choice and starting doses and to reduce trial‑and‑error. Genes are only part of the picture; regular follow‑up, lifestyle guidance (including exercise limits), and device therapy remain central parts of care for people living with Naxos disease.
Interactions with other conditions
Living day-to-day with Naxos disease, heart rhythm problems can flare when another illness is in the mix—especially thyroid disorders, sleep apnea, or anything that causes dehydration and electrolyte shifts from vomiting or diarrhea. Doctors call it a “comorbidity” when two conditions occur together, and in this setting one problem can nudge the heart into faster or more irregular beats. Because early symptoms of Naxos disease—like pounding heartbeats, lightheadedness, or fainting—also show up in conditions such as sleep apnea or anemia, one condition can mask the other and delay the right treatment. Some medicines used for infections, mood, or allergies can strain the heart’s rhythm control, so it’s important to review antibiotics, antifungals, decongestants, and stimulants with your care team before starting them. Naxos disease also overlaps biologically with other inherited heart muscle conditions; some conditions share “underlying mechanisms,” such as changes in the proteins that help heart cells stick together. On the skin side, thickened palms and soles can crack and invite bacterial or fungal infections, so prompt care for skin breaks helps prevent added stress on the heart.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described families in coastal towns where several relatives had thick, woolly hair from birth, rough palms and soles that cracked with work, and later, heart trouble in adolescence. Community stories often described the condition as “the family heart problem that shows first in the hair and skin,” linking everyday signs to a risk that tended to appear years later.
First described in the medical literature as a cluster of skin and heart findings on the Greek island of Naxos in the late 20th century, Naxos disease became a clue to a larger story about the heart’s structure. Doctors noted that teens and young adults developed fainting episodes during exercise, irregular heartbeats, or—rarely—sudden cardiac arrest, while earlier life featured thickened skin on the hands and feet and tightly curled hair. From these first observations, researchers began to suspect an inherited condition that affects both the outer barrier of the body and the heart muscle.
As medical science evolved, careful family studies showed that Naxos disease follows an autosomal recessive pattern—often appearing when both parents carry the same silent change in a gene and a child inherits both copies. Advances in genetics confirmed that the underlying problem involves proteins that help cells stick together like strong rivets. When these “rivets” are weakened, outer skin can thicken and toughen, and the heart’s right ventricle is prone to scarring and rhythm problems. This helped connect Naxos disease to a broader group of conditions called arrhythmogenic cardiomyopathy.
Over time, descriptions became more precise. Clinicians recognized that early symptoms of Naxos disease may be subtle skin changes in childhood, while heart features may not appear until the teen years or early adulthood. They also learned that not every person has the same course—some have milder skin findings, others develop more serious rhythm issues—yet the combination of hair, skin, and heart clues guides diagnosis.
In recent decades, knowledge has built on a long tradition of observation. Genetic testing became available, family screening improved, and treatment shifted toward preventing dangerous rhythms, protecting the heart during activity, and supporting skin care. Awareness grew beyond the Aegean region, with similar cases reported in other Mediterranean areas and beyond, showing that while Naxos disease was first linked to one island community, it is not limited to a single place.
Looking back helps explain today’s approach: noticing the early skin and hair signs can prompt timely heart checks and family counseling. The history of Naxos disease—moving from community stories to genetic insight—continues to shape how doctors monitor, treat, and support people living with this condition.